Trials / Sponsors / Cellxpert Biotechnology Corp.
Cellxpert Biotechnology Corp.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resect Cancer, Liver Cancer, Hepatocellular Carcinoma | Phase 3 | 2011-08-01 |
| Completed | Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma Melanoma | Phase 2 | 2005-06-01 |
| Completed | PI-88 in Hepatocellular Carcinoma After Hepatectomy Carcinoma, Hepatocellular | Phase 2 | 2004-06-01 |
| Completed | Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2004-02-01 |
| Completed | Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 2 | 2004-02-01 |
| Completed | PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | 2004-01-01 |
| Completed | Study of PI-88 in Patients With Advanced Melanoma Melanoma | Phase 1 / Phase 2 | 2001-07-01 |